Long-term results of surgical management of pulmonary metastases from renal cell carcinoma

Thorac Cardiovasc Surg. 2006 Dec;54(8):544-7. doi: 10.1055/s-2006-924414.

Abstract

Background: Metastatic renal cell carcinoma (RCC) has a poor prognosis and conventional treatments such as chemoradiotherapy show little efficacy. Surgical resection of pulmonary metastases from RCC is a widely accepted treatment, even if selection criteria based on prognostic factors have still not been defined. The aim of this study was to determine the long-term survival, clinical outcome and prognostic factors after surgery.

Methods: Between 1988 and 2004, 59 patients underwent resection of pulmonary metastases from RCC. Univariate and multivariate analysis of prognostic factors was carried out.

Results: Complete resection was achieved in 54 (91.5 %) patients. No intra- or postoperative mortality occurred, 5 (8.5 %) patients experienced postoperative complications. Overall, the 1-, 3-, and 5-year survival rates were 86.5 %, 63 % and 53 %, respectively. Age at the time of pulmonary resection was found to be the only independent factor influencing prognosis.

Conclusion: Pulmonary resection of metastases from RCC is a safe and effective treatment associated with a low morbidity and mortality and with high long-term survival. The lack of other effective therapies suggests use of the surgical approach whenever possible.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Renal Cell / secondary*
  • Carcinoma, Renal Cell / surgery*
  • Carcinoma, Renal Cell / therapy
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Immunotherapy
  • Kidney Neoplasms / pathology*
  • Kidney Neoplasms / surgery
  • Kidney Neoplasms / therapy
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Nephrectomy
  • Prognosis
  • Radiotherapy, Adjuvant
  • Thoracotomy
  • Treatment Outcome